A carregar...
Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells
The identification of novel antimetastatic therapeutic targets is necessary for improved treatment of patients with acquired BRAF inhibitor‐resistant (BRAFi‐R) melanoma, in whom metastasis is a major concern. Our present study focused on the identification of such targets to explore novel antimetast...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360505/ https://ncbi.nlm.nih.gov/pubmed/30582770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12433 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|